| CXSL2400386 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(3.3) | New Drug Application | 2024-06-14 | | | | | view |
| CXSL2300579 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(3.3) | New Drug Application | 2023-08-29 | | Shanghai Henlius Biotech Co Ltd | | | view |
| CXSL2101329 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-09-16 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSL2101270 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-08-23 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSL2101226 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-07-30 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSL2101225 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-08-03 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSL2101221 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-07-28 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSL1900059 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-06-26 | 三生国健药业（上海）股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2019-06-25 | view |
| CXSL1900027 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2019-03-25 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | In Review | 2019-03-22 | view |
| CXSL1800070 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-07-20 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-09-03 | view |
| CXSL1700073 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2017-08-07 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-03-20 | view |
| CXSB2101026 | 重组抗PD-1人源化单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | Supplementary Application | 2021-07-08 | | Shanghai Henlius Biotech Co Ltd | | | view |
